Validation and Potential Mechanisms of Red Cell Distribution Width as a Prognostic Marker in Heart Failure

Journal of Cardiac Failure

Volumn 16, Issue 3, 2010, Pages 230-238

  Allen, Larry A ^a   Felker, G Michael ^b   Mehra, Mandeep R ^c   Chiong, Jun R ^d   Dunlap, Stephanie H ^e   Ghali, Jalal K ^f   Lenihan, Daniel J ^g   Oren, Ron M ^h   Wagoner, Lynne E ⁱ   Schwartz, Todd A ^j   Adams Jr , Kirkwood F ^k  

^a UNIVERSITY OF COLORADO   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f DETROIT MEDICAL CENTER   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h Mercy Iowa City   (United States)

ⁱ Greater Cincinnati Cardiovascular Consultants   (United States)

^j University of North Carolina at Chapel Hill   (United States)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Anemia; biomarker; laboratory tests

Indexed keywords

NEUROHORMONE;

ADULT; AGED; ARTICLE; ERYTHROCYTE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; INFLAMMATION; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REGISTER; VALIDATION STUDY;

AGED; BIOLOGICAL MARKERS; CAUSE OF DEATH; COHORT STUDIES; ERYTHROCYTE INDICES; ERYTHROCYTES; ERYTHROPOIESIS; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 77549085145     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.11.003     Document Type: Article

References (28)

1. Al-Ahmad A., Rand W.M., Manjunath G., Konstam M.A., Salem D.N., Levey A.S., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 955-962
2. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., and Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780-1786
3. Mozaffarian D., Nye R., and Levy W.C. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 41 (2003) 1933-1939
4. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
5. Felker G.M., Gattis W.A., Leimberger J.D., Adams K.F., Cuffe M.S., Gheorghiade M., et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 92 (2003) 625-628
6. Tang Y.D., and Katz S.D. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 113 (2006) 2454-2461
7. Ghali J.K. Anemia and heart failure. Curr Opin Cardiol 24 (2009) 172-178
8. van Veldhuisen D.J., and McMurray J.J. Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. Eur J Heart Fail 9 (2007) 110-112
9. Felker G.M., Adams Jr. K.F., Gattis W.A., and O'Connor C.M. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959-966
10. Felker G.M., Allen L.A., Pocock S.J., Shaw L.K., McMurray J.J., Pfeffer M.A., et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50 (2007) 40-47
11. Tonelli M., Sacks F., Arnold M., Moye L., Davis B., and Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117 (2008) 163-168
12. Cavusoglu E., Chopra V., Gupta A., Battala V.R., Poludasu S., Eng C., et al. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol (2009) article in press
13. Patel K.V., Ferrucci L., Ershler W.B., Longo D.L., and Guralnik J.M. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 169 (2009) 515-523
14. Perlstein T.S., Weuve J., Pfeffer M.A., and Beckman J.A. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 169 (2009) 588-594
15. Adams Jr. K.F., Patterson J.H., Oren R.M., Mehra M.R., O'Connor C.M., Pina I.L., et al. Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Am Heart J 157 (2009) 926-932
16. Adams K.F., O'Connor C.M., Oren R.M., Ventura H.O., Pina I., Gattis W.A., et al. Development of a multicenter heart failure database: initial report from the United Investigators to Evaluate Heart Failure [abstract]. J Card Fail 6 (2000) S2-56
17. World Health Organization. Iron deficiency anemia, assessment, prevention, and control: report of a WHO Scientific Group (2001), WHO, Geneva, Switzerland
18. Minetti M., Agati L., and Malorni W. The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res 75 (2007) 21-28
19. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
20. Opasich C., Cazzola M., Scelsi L., De Feo S., Bosimini E., Lagioia R., et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 26 (2005) 2232-2237
21. Nanas J.N., Matsouka C., Karageorgopoulos D., Leonti A., Tsolakis E., Drakos S.G., et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 48 (2006) 2485-2489
22. Westenbrink B.D., Voors A.A., and van Veldhuisen D.J. Is anemia in chronic heart failure caused by iron deficiency?. J Am Coll Cardiol 49 (2007) 2301-2302
23. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
24. De Domenico I., Ward D.M., and Kaplan J. Hepcidin regulation: ironing out the details. J Clin Invest 117 (2007) 1755-1758
25. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110 (2002) 1037-1044
26. Lee P., Peng H., Gelbart T., Wang L., and Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 102 (2005) 1906-1910
27. Chiari M.M., Bagnoli R., De Luca P.D., Monti M., Rampoldi E., and Cunietti E. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc 43 (1995) 767-771
28. Pierce C.N., and Larson D.F. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20 (2005) 83-90